Funding for this research was provided by:
Japan Agency for Medical Research and Development (19ek0210082h0003)
Received: 23 November 2020
Accepted: 22 March 2021
First Online: 31 March 2021
: This study was approved by the ethics committees of the HSRC.
: Not applicable.
: HT received research funding from Boehringer Ingelheim, Bayer, Daiichi-Sankyo, and Pfizer, and Speakers’ Bureau/Honorarium from Boehringer Ingelheim, Bayer, Daiichi-Sankyo, and Bristol-Myers Squibb. The rest of the authors have no relevant disclosures.